Hi friends,
Fertility technology is having a moment. AI is grading embryos. Robots are performing procedures, and a $30 test kit from the internet can now measure hormones that used to require a clinic visit and a referral. If you’ve been anywhere near a fertility waiting room, a TTC forum, or a late-night Google spiral, you’ve probably seen the headlines. The question is whether any of it actually changes your experience.
This week, we went deep on two pieces of that puzzle. The first looks inside the IVF lab at what artificial intelligence and automation are really doing (and not doing) with your embryos. The second looks at what happens before you ever reach the lab: the growing world of at-home fertility tests that promise to put real hormonal data in your hands. Different stages of the journey, same question: does this technology help, and how do you use it wisely?
Let’s get into it.
In this Issue We’ll Cover...
Smart Labs, Real Questions: A Guide to AI in Fertility Treatment
The FDA just cleared the first AI-powered embryo assessment tool. A startup announced babies born from fully automated IVF. And the headlines say robots are “picking” your embryo. But what’s actually happening in the lab is more nuanced, more human, and more interesting than the clickbait suggests. We break down how AI embryo grading works, what the largest clinical trial found (spoiler: it didn’t show a benefit), where robotics could genuinely expand access, and what questions are worth asking your clinic.
Tech, Access & the Future of Fertility: What We’re Reading This Week
This week’s articles are about the growing role of technology in fertility care, from the algorithms analyzing embryos to the test strips on your bathroom counter. That shift is happening fast, and the conversation around it is evolving just as quickly. Here are some recent pieces that dig deeper into the themes we covered this week:
The Role of Robotics on IVF
The Washington Post reports on how AI-powered robots are automating 205 steps in the IVF process, reducing human error and potentially expanding access to underserved areas. The piece features the Aura system by Conceivable Life Sciences, which has already produced 19 babies through automated procedures, and explores what this means for the future cost and availability of fertility treatment. READ ARTICLE
Next Frontier in Reproductive Technology Demands Tough Conversations
STAT News examines the emerging technologies that are outpacing regulation: stem cell-derived gametes, AI-assisted polygenic embryo screening, and tools that could enable entirely new pathways to parenthood. The piece makes a compelling case that the ethics conversation needs to catch up with the science before these tools reach widespread clinical use. READ ARTICLE
Maven Clinic Will Soon Offer Virtual Care to All Women
TIME reports on Maven Clinic’s expansion of telehealth fertility services to all U.S. women starting May 2026, a signal of how quickly the care model is shifting. For readers wondering how at-home testing fits into the bigger picture, this is the infrastructure being built around it: remote consultations, virtual monitoring, and clinic visits only when hands-on care is truly needed. READ ARTICLE
The Lab in Your Pocket: How At-Home Fertility Tests Are Reshaping TTC
If you’ve ever Googled “fertility test I can do at home” because you weren’t ready for a clinic appointment but couldn’t stand the waiting, this one’s for you. The at-home fertility testing market has nearly doubled in recent years, and some of these kits deliver real clinical insight. But more options doesn’t mean better information. We break down what today’s tests actually measure (urine monitors vs. blood panels vs. male fertility kits), how accurate they really are, the false reassurance problem that nobody puts on the box, and five ways to make the most of the data you get.
If you enjoyed this issue of Path to Parenthood, be sure to share with anyone you know who is currently on a TTC journey ❤
